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Abstract
Celiac disease (CD) is an immune-mediated enteropathy that is characterized by intraepithelial lymphocytosis, crypt
hyperplasia, and villous atrophy. Prevalence is high and has been estimated to range between 0.5% and 1.5%. Capsule
endoscopy (CE) has a sensitivity and speciﬁcity of approximately 90%. CD is an important differential diagnosis for
diagnostic workup for anemia, malabsorption, or diarrhea, and must be recognized reliably by the investigator. Moreover,
CE is the preferred method to screen for complications in CD, such as enteropathy-associated T-cell lymphoma, ulcerative
jejunitis, and small bowel adenocarcinoma. This article is part of an expert video encyclopedia.
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Video Related to this Article
Technique
Capsule endoscopy.
Materials
• Capsule endoscope: PillCam SB2; Given Imaging EMEA,
Hamburg, Germany.
• RAPID 6 and Rapid Reader 7; Given Imaging EMEA,
Hamburg, Germany.
• GIF-H180 and EVIS EXERA II CV-180; Olympus Europe,
Hamburg, Germany.
Background and Endoscopic Procedure
Celiac disease (CD) is an immune-mediated enteropathy
caused by mucosal exposure to wheat gluten in genetically
susceptible persons, and HLA-DQ2 is found in 95% of the
patients. Histologically, the bowel mucosa is characterized by
intraepithelial lymphocytosis, crypt hyperplasia, and villous
atrophy in affected subjects. Prevalence in the populations of
North America and Western Europe is high and has been es-
timated to range between 0.5% and 1.5%. Four subtypes of
clinical symptoms have been characterized: classical, atypical,
silent, and latent celiac disease. With classical CD, typical
symptoms such as diarrhea, abdominal distension, failure to
thrive, or weight loss are predominant, and quite often this is a
manifestation in early childhood. In atypical CD, iron de-
ﬁciency anemia, osteoporosis, arthritis, infertility, peripheral
neuropathy, and abnormal liver function tests are accom-
panied by a variable degree of mucosal damage. Manifest
villous atrophy in asymptomatic persons is called silent CD.
Latent CD characterizes minor or no symptoms in patients
with mild mucosal inﬂammation or immune activation and
might present an early manifestation of the disease. Mucosal
alterations such as atrophy are reliably detected by high-
resolution endoscopy, but isolated lymphocyte inﬁltration of
the mucosal layer without overt atrophy can hardly be visu-
alized. In studies, capsule endoscopy (CE) has a sensitivity and
speciﬁcity of approximately 90% to detect CD. Up to now, CE
is not used as a screening method for CD. Serological tests
(e.g., IgA and IgG-tissue transglutaminase, tTG, IgA-endomy-
sial antibodies, EMA) and biopsies from the deep duodenum
are the standard reference. Nevertheless, CE is the preferred
method to screen for complications in CD, such as entero-
pathy-associated T-cell lymphoma (EATL), ulcerative jejunitis,
and small bowel adenocarcinoma.
Key Learning Points/Tips and Tricks
• CD is an important differential diagnosis at CE.
• Villous atrophy is detected reliably by CE, but early stages
without atrophy may be missed with this technique.
Scripted Voiceover
This is a case of a 32 year old female patient with severe
malnutrition and diarrhea.
The capsule endoscope is passing the pylorus.
The descending duodenum is rapidly traversed; bile is seen
within the lumen.
There is complete villous atrophy visualized in the duo-
denum and the proximal small bowel: Submucosal vessels are
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showing through, there is a loss of the duodenal and jejunal
folds, and a nodular and mosaic pattern of the mucosa with
scalloping of the circular folds may be noticed.
The magniﬁcation and motion views of capsule endoscopy
enhance the detection of atrophy with a sensitivity of ap-
proximately 90%, but early stages such as ‘‘Marsh classiﬁ-
cation’’ stage 1 and 2 may be missed with this technique.
Complete visualization of the small bowel and high sen-
sitivity for small bowel lesions favor the use of capsule en-
doscopy in patients in whom complications of celiac disease
are suspected.
Capsule endoscopy ﬁndings resemble high-resolution
upper gi-tract video-endoscopy.
Mosaic pattern of the mucosa and scalloping of the circular
folds is well demarcatedy
yand might even better been visualized with use of op-
tical enhancement techniques such as narrow-band imaging.
Severe villous atrophy in the upper third of the small bowel
contrasts well with the deeper parts of the small bowel in this
case where normal mucosa is seen. Atrophy decreases and the
mucosal architecture may normalize with progressing into the
lower small bowel in many patients, but patchy manifest-
ations of celiac disease have also been described.
Capsule endoscopy is useful to exclude enteropathy-asso-
ciated T-cell lymphoma (EATL), ulcerative jejunitis, and small
bowel adenocarcinoma. In case any of these complications of
celiac disease were detected by video capsule endoscopy, plans
can be made with balloon-assisted endoscopy to obtain spe-
ciﬁc samples for histologic review.
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